Abstract All newborn infants in East
days), despite receiving more than double the number of courses of antibiotics than group P infants (in addition to flucloxacillin). Continuous [84] [85] [86] [87] [88] [89] With the development of methods to identify infants with cystic fibrosis during the neonatal periodl opportunities to intervene early in the course of the disease have become available.
The criteria by which the value of a screening programme may be judged require (i) that the disease is an important health problem for the individual and the community, (ii) that its natural history is known, (iii) that it has a latent or asymptomatic phase, (iv) that it may be identified by a suitable screening test, (v) that facilities for diagnosis and treatment are available, and (vi) that its natural history may be favourably modified by early treatment, which (vii) is acceptable and cost effective. 2 With respect to cystic fibrosis, criteria (i), (iii), (iv), and (v) have been fulfilled: the prevalence of cystic fibrosis in the UK is about 5000,3 the disease is often not recognised until well into childhood,4 it may be accurately identified by neonatal immunoreactive trypsin screening and sweat test,' and facilities for its treatment are widely available. The aim of this study was to address criteria (ii), (vi), and (vii).
Since 1981 all infants born in East Anglia have been screened by blood immunoreactive trypsin assay. We reported the incidence, clinical presentation, biochemical and genotypic characteristics, and early natural history of cystic fibrosis in these children elsewhere.5
In this paper we describe the effects of continuous prophylactic antibiotic treatment on the clinical progress of infants born with cystic fibrosis between 1985 (10) 121 (9) 108 (9) 254 (18) 100 (14) 5 (25) 2 (10) 5 (25) 8 (40) gestational ages, or sex distributions. All were detected by neonatal immunoreactive trypsin screening: there was no significant difference in mean blood immunoreactive trypsin concentrations measured at 7 days and at 4 weeks. There was no significant difference in the distribution of genotypes between the two groups. Mean (SD) age of diagnostic sweat test was 7 (3) weeks in group P and 5 (3) weeks in group E (not significant). There were no significant differences in mean sweat osmolalities or sodium concentrations between the two groups. At the time of diagnosis 72% of infants in group P and 60% of infants of group E had symptoms.
The parents of 34 (89%) infants were married or enjoyed stable relationships. Four infants were born of single mothers into one parent families. The mean (SD) age of mothers of group P was 28-4 (4.9) years, and of fathers was 31-6 (6 6) years. The mean age of mothers of group E was 27-8 (5-7) years, and of fathers was 29-2 (5 5) years. The social class distribution was equal between the two groups. Cigarettes were smoked in 22% of households (n=4) of group P (mean of 5 cigarettes/day) and in 33%/o of households (n=6) in group E (mean of 8 cigarettes/day); this difference was not significant.
The proportion of infants breast fed at diagnosis was 53% of group P and 16% of group E, and at six months was 7% and 0% respectively. Mixed feeding began within six months in all children and by 12 months 100% of infants were fully weaned to a solid diet. Pancreatic enzyme supplements were taken by all children from diagnosis. Acie (months) Figure 2 SD (z) scores of length for age ofsubjects followed up from birth to 24 months. Figure 1 shows the changes in weight for age z scores at monthly intervals from diagnosis to two years. Starting with z scores ofbetween 1*5 and 2 SDs below the mean at diagnosis, the weights for age of both groups of infants reached within 05 SD of the mean by one year. Figure 2 shows the length for age z scores which increased from below -05 SD at birth to above -0-5 SD during the second year. There was no significant difference in the growth curves between the two groups.
ANTHROPOMETRY

MICROBIOLOGY
The rate of isolation of bacteria from the respiratory and gastrointestinal tracts of children in the two groups are shown in table 2. Specimens positive for S aureus were obtained from the upper respiratory tract of 12 children of group E (60%) during 32 infant months compared with positive specimens from three children (17%) of group P during six infant months (p<0 0 1).
P aeruginosa was isolated from four (22%) children in group P; from the upper respiratory tract on three (1%) infant months (from two (1 %) children); from the stools on 22 (10%) infant months (from four (22%) children), and from two children out of four isolation was from both stool and respiratory tract.
P aeruginosa was isolated from the upperrespiratory tract of the children in group E on 10 (4%) infant months (from six (33%) children), and from the stools on 23 (8%) infant months (from six (33%/o) children). In 3/9 children specimens from both upper respiratory tract and stool were positive, in three from the respiratory tract only, and in three from the stool only. The difference in isolation rates of P aeruginosa from the upper respiratory tract between the two groups was not significant (p<0-1).
H influenzae was isolated from seven infants (39%) of group P in 10 (5%) infant months. From the children of group E A influenzae was isolated in 25 (10%) infant months, from 10 (50°/o) of the children. The difference between these two isolation rates was not significant. S pneumoniae was isolated from six children (33%) of group P in 18 (8%) infant months, and from 10 (50%) children of group E in 25 (9%) infant months. There was no significant difference in these isolation rates.
Viruses isolated from the respiratory tract included respiratory syncytial virus, adenovirus, Coxsackie A and B, influenza types A and B, and parainfluenza type 3. There was no significant difference in the isolation rates between the two groups.
ANTIMICROBIAL TREATMENT Children of group E received an average of 8-3 courses of antibiotics per year, and those in group P an average of 3-7 courses per year. The range of antimicrobial agents prescribed is shown in table 3. The courses of flucloxacillin received by children of group P represent a doubling of the dose of this antibiotic.
HOSPITAL ADMISSIONS
The frequency and duration of hospital admissions was lower in the infants and children who received continuous prophylactic antibiotics (group P) than in those who received them episodically (group E) (table 4). The total number of admissions for group P was 23, and for group E was 40 (p<0-0 1). This difference was largely in the second year of life, when there were only five child admissions (five children) in group P compared with 19 child admissions (12 children) in group E (p<O0Ol). The mean (SE) duration of admission of these children during the first year was not significantly different, but in the second year those children receiving continu- Population screening of newborns for cystic fibrosis has become established in several parts of the world. 1 4 11 Retrospective studies have suggested that early diagnosis, and therefore treatment, is beneficial in the long term.4 1213 However, the conclusions of these studies have been clouded by changes in treatment during the study period, the lack of proper control groups, and their retrospective design. In a prospective study that compared the outcome of infants identified by screening with those who presented later clinically,'4 subjects were not properly matched for duration of treatment.
In the randomised, prospective, intervention study reported here we have shown that the natural history of cystic fibrosis may be favourably modified by early treatment, which is acceptable and cost effective, and in so doing that the criteria that justify the implementation of the screening programme2 have been fully met.
NEONATAL, CLINICAL, BIOCHEMICAL, AND GENETIC DATA
There were no significant differences in the neonatal characteristics of the two groups (table 1). The distribution of the sexes, gestational ages, birth weights, and genotypes between the two groups was similar. There was a greater number of infants with meconium ileus in group E. However, immunoreactive trypsin screening alone identified 72% of infants of group P and 60% of those of group E. The mean age of sweat test was similar in the two groups, and at diagnosis greater than 60% of infants had symptoms. We have discussed the significance of these data, which do not differ significantly from those of other workers, 0 12 15 elsewhere. 5 SOCIAL AND DOMESTIC DATA There were no significant differences in the social and domestic circumstances of the families of the two groups, and both received equal support from the nurse coordinator.
NUTRITION, FEEDING, AND, ANTHROPOMETRY
Although there were differences in the choice of feeding in early infancy, by six months all infants were receiving a mixed diet, and by one year all were fully weaned to a solid diet.
We took advantage of modern, locally collected growth standards to compare the growth performance of infants with cystic fibrosis with healthy controls. 7 The weight growth of the children in the two groups with cystic fibrosis was comparable: both showed an increase in weight for age z scores from between -1-5 and -2 at diagnosis to close to 0 by 12 months. The overall pattern of growth of both groups was similar to that reported elsewhere. '6 The variation over time between some of the points in the height for age z scores is an indication of the difficulties of measuring body length accurately in wriggling toddlers, bearing in mind that a z score of 0-5 SD at 12 months represents 1-5 cm, and repeatability of measurements is around ±0 5 cm.
MICROBIOLOGY
The results show a significant reduction, when prophylactic flucloxacillin is given, in both the number of children colonised and in the number of months in which S aureus was isolated. No flucloxacillin resistant strains of this organism were isolated, and no child receiving continuous treatment developed candidiasis.
There was a positive association between prior or concurrent carriage of S aureus and colonisation with P aeruginosa in patients in group E. Such a pattern has been described in another prospective study. 6 The impact of the unexpected news of the diagnosis of a chronic disease requiring life long care may be considerably reduced with the availability of expert advice and treatment,21 particularly during the period when the diagnosis is being established. 22 Counselling and support of parents immediately at diagnosis and for the first year thereafter should be an integral part of any neonatal screening programme.
Nutritional deficits are present from an early age23 24 and chest infection leads to deteriorating respiratory function.'8 Interventions therefore should be aimed primarily at ensuring optimal nutrition and preventing pulmonary infection. We have shown that close monitoring and support, with commencement of pancreatic enzyme supplements and physiotherapy from diagnosis, is associated with a return to normal growth centiles by 1 year of age. In addition, continuous oral flucloxacillin treatment is associated with fewer hospital admissions, less clinical morbidity, and lower rates of S aureus isolation than in children who do not receive such antibiotic prophylaxis. 
